The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine
Abstract
Abstract: Repeated methamphetamine (METH) administration to animals can result in long‐lasting decreases in brain dopamine (DA) and serotonin (5‐HT) content. Calcitriol, the active metabolite of vitamin D, has potent effects on brain cells, both in vitro and in vivo, including the ability to upregulate trophic factors and protect against various lesions. The present experiments were designed to examine the ability of calcitriol to protect against METH‐induced reductions in striatal and nucleus accumbens levels of DA and 5‐HT. Male Fischer‐344 rats were administered vehicle or calcitriol (1μg/kg, s.c.) once a day for eight consecutive days. After the seventh day of treatment the animals were given METH (5 mg/kg, s.c.) or saline four times in 1 day at 2‐h intervals. Seven days later the striata and accumbens were harvested from the animals for high‐performance liquid chromatography (HPLC) analysis of monoamines and metabolites. In animals treated with vehicle and METH, there were significant reductions in DA, 5‐HT, and their metabolites in both the striatum and accumbens. In animals treated with calcitriol and METH, the magnitude of the METH‐induced reductions in DA, 5‐HT, and metabolites was substantially and significantly attenuated. The calcitriol treatments did not reduce the hyperthermia associated with multiple injections of METH, indicating that the neuroprotective effects of calcitriol are not due to the prevention of increases in body temperature. These results suggest that calcitriol can provide significant protection against the DA‐ and 5‐HT‐depleting effects of neurotoxic doses of METH.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The brain chemistry of children with ASD may differ from that of children with developmental delay [142], and as such the response to vitamin D supplement—that may affect brain chemistry [143]—could vary.”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [143]
In the citing paper
“Pre-treatment with calcitriol has been shown to protect rats’ striatum and accumbens from methamphetamine-induced reduction in dopamine and serotonin [143].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [143]
Citations
Cites
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995) · Nature · doi:10.1038/373335a0 · Cited by 1,079
Functional recovery in parkinsonian monkeys treated with GDNF
Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) · Nature · doi:10.1038/380252a0 · Cited by 955
Self-citationThe Pharmacological Basis of Therapeutics.
Goodman, L., & Gilman, A. G. (1941) · Anesthesia & Analgesia · doi:10.1213/00000539-194101000-00064 · Cited by 604
Hoffer, B. J., Hoffman, A. F., Bowenkamp, K., Huettl, P. F., Hudson, J., Martin, D., Lin, L.-F. H., & Gerhardt, G. A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90218-6 · Cited by 453
Winkler, C., Sauer, H., Lee, C. S., & Björklund, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-22-07206.1996 · Cited by 258
Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats
Wang, J., Wu, J.-N., Cherng, T.-L., Hoffer, B. J., Chen, H.-H., Borlongan, C. V., & Wang, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02450-7 · Cited by 242
Ibi, M., Sawada, H., Nakanishi, M., Kume, T., Katsuki, H., Kaneko, S., Shimohama, S., & AKAIKE, A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00009-0 · Cited by 233
1,25(OH)2 vitamin D3 sites of action in the brain
Stumpf, W. E., & O'Brien, L. P. (1987) · Histochemistry and Cell Biology · doi:10.1007/bf00496810 · Cited by 218
Garcion, E., Sindji, L., Leblondel, G., Brachet, P., & Darcy, F. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730859.x · Cited by 213
1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor
Naveilhan, P., Neveu, I., Wion, D., & Brachet, P. (1996) · Neuroreport · doi:10.1097/00001756-199609020-00023 · Cited by 213
Vitamin D3 attenuates cortical infarction induced by middle cerebral arterial ligation in rats
Wang, Y., Chiang, Y., Su, T., HAYASHI, T., Morales, M., Hoffer, B. J., & Lin, S. Z. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00255-5 · Cited by 212
1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes
Neveu, I., Naveilhan, P., Baudet, C., Brachet, P., & METSIS, M. L. (1994) · Neuroreport · doi:10.1097/00001756-199412300-00032 · Cited by 196
Sonnenberg, J. L., Luine, V. N., Krey, L. C., & Christakos, S. (1986) · Endocrinology · doi:10.1210/endo-118-4-1433 · Cited by 176
Rosenblad, C., Martı́nez-Serrano, A., & Björklund, A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00269-8 · Cited by 152
Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells
Puchacz, E., Stumpf, W. E., Stachowiak, E. K., & Stachowiak, M. K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00314-i · Cited by 140
GDNF Protection against 6-OHDA: Time Dependence and Requirement for Protein Synthesis
Kearns, C. M., Cass, W. A., Smoot, M. K., Kryscio, R. J., & Gash, D. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-18-07111.1997 · Cited by 131
Self-citationSynthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro
Neveu, I., Naveilhan, P., Menaa, C., Wion, D., Brachet, P., & Garabédian, M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490380212 · Cited by 114
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
Balabanova, S., Richter, H., Antoniadis, G., Homoki, J., Kremmer, N., Hanle, J., & Teller, W. M. (1984) · Journal of Molecular Medicine · doi:10.1007/bf01711378 · Cited by 108
Cass, W. A., Harned, M. E., Peters, L. E., Nath, A., & Maragos, W. F. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03122-6 · Cited by 100
Self-citationCass, W. A. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-24-08132.1996 · Cited by 99
Self-citationBeckstrøm, H., Julsrud, L., Haugeto, Ø., Dewar, D., Graham, D. I., Lehre, K. P., Storm‐Mathisen, J., & Danbolt, N. C. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990115)55:2 · Cited by 96
Sullivan, A. M., Opacka‐Juffry, & Blunt (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00016.x · Cited by 92
Schumann, R. R., Pfeil, D., Freyer, D., Bürger, W., Lamping, N., Kirschning, C. J., Göbel, U. B., & Weber, J. R. (1998) · Glia · doi:10.1002/(sici)1098-1136(199803)22:3 · Cited by 92
Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain
Gascon‐Barré, M., & Huet, P. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.244.3.e266 · Cited by 75
Systemic Vitamin D3 Attenuated Oxidative Injuries in the Locus Coeruleus of Rat Brain
CHEN, K., Lin, A. M.-Y., & Chiu, T. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07539.x · Cited by 74
1,25-Dihydroxyvitamin D3 increases striatal GDNF mRNA and protein expression in adult rats
Sánchez, B., López-Martín, M. E., Segura, C., Labandeira-García, J. L., & Pérez-Fernández, R. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00545-4 · Cited by 66
Kojima, H., Abiru, Y., Sakajiri, K., Watabe, K., Ohishi, N., Takamori, M., Hatanaka, H., & Yagi, K. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7183 · Cited by 63
Veenstra, T. D., Windebank, A. J., & Kumar, R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6718 · Cited by 37
GDNF Protection against 6-OHDA–Induced Reductions in Potassium-Evoked Overflow of Striatal Dopamine
Cass, W. A., & Manning, M. W. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01416.1999 · Cited by 31
Self-citationEffects of 1,25-dihydroxyvitamin D3 on growth of mouse neuroblastoma cells
Veenstra, T. D., Londowski, J. M., Windebank, A. J., Brimijoin, S., & Kumar, R. (1997) · Developmental Brain Research · doi:10.1016/s0165-3806(96)00196-4 · Cited by 31
Cass, W. A., Manning, M. W., & Bailey, S. L. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05190.x · Cited by 17
Self-citation
Cited by
Sorted by citations
Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.07.001 · Cited by 726
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
de Abreu, D. A. F., Eyles, D. W., & Feron, F. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.023 · Cited by 392
Review: The role of vitamin D in nervous system health and disease
DeLuca, G. C., Kimball, S., Kolasinski, J., Ramagopalan, S. V., & Ebers, G. C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12020 · Cited by 340
Spedding, S. J. (2014) · Nutrients · doi:10.3390/nu6041501 · Cited by 304
Metadata
- Authors
- CASS, W. A., SMITH, M. P., & PETERS, L. E.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- CASS, WAYNE A.
- ORCID
- CASS, WAYNE A.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2006-08
- Volume
- 1074
- Issue
- 1
- Pages
- 261-271
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2087559183
- Cited by
- 149
- References
- 32
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 4 · 2021: 9 · 2020: 15 · 2019: 10 · 2018: 14 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 16 · 2013: 10 · 2012: 10
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29da010115-05)
- U.S. Public Health Service
- National Institute on Aging (R01AG017963, AG17963)
- National Institute on Drug Abuse (DA 10115)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- 1,25-dihydroxyvitamin D3, methamphetamine, dopamine depletion, serotonin depletion, neuroprotection, striatum, nucleus accumbens, monoamine metabolites, hyperthermia, neurotoxicity, vitamin D metabolites
- MeSH terms
- Animals, Calcitriol, Corpus Striatum, Dopamine, Drug Interactions, Hyperthermia, Induced, Male, Methamphetamine, Nucleus Accumbens, Rats, Inbred F344, Serotonin, Dopamine Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
